Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2025-02-14 9:00 pm Purchase |
2025-02-07 | 13G | ArriVent BioPharma, Inc. Common Stock AVBP |
Novo Holdings A/S | 1,750,000 5.200% |
1,750,000 (New Position) |
Filing History |
| 2024-12-04 4:32 pm Purchase |
2024-11-26 | 13G | ArriVent BioPharma, Inc. Common Stock AVBP |
SUVRETTA CAPITAL MANAGEMENT, LLC | 2,040,365 6.100% |
2,040,365 (New Position) |
Filing History |
| 2024-11-14 4:33 pm Purchase |
2024-09-30 | 13G | ArriVent BioPharma, Inc. Common Stock AVBP |
HHLR Advisors, Ltd. | 4,484,672 13.400% |
4,484,672 (New Position) |
Filing History |
| 2024-11-12 2:45 pm Purchase |
2024-09-30 | 13G | ArriVent BioPharma, Inc. Common Stock AVBP |
Sofinnova Venture Partners XI L.P. | 1,696,752 5.100% |
1,696,752 (New Position) |
Filing History |
| 2024-11-12 09:50 am Purchase |
2024-11-08 | 13G | ArriVent BioPharma, Inc. Common Stock AVBP |
FMR CORP | 2,119,695 6.311% |
2,119,695 (New Position) |
Filing History |
| 2024-11-08 2:17 pm Unchanged |
2024-09-30 | 13G | ArriVent BioPharma, Inc. Common Stock AVBP |
BLACKROCK INC BLK |
1,931,419 5.800% |
0 (Unchanged) |
Filing History |
| 2024-10-24 2:02 pm Purchase |
2024-09-30 | 13G | ArriVent BioPharma, Inc. Common Stock AVBP |
BLACKROCK INC BLK |
1,931,419 5.800% |
1,931,419 (New Position) |
Filing History |
| 2024-10-11 4:02 pm Purchase |
2024-09-30 | 13G | ArriVent BioPharma, Inc. Common Stock AVBP |
Octagon Capital Advisors LP | 1,976,387 5.900% |
1,976,387 (New Position) |
Filing History |
| 2024-02-13 5:20 pm Purchase |
2024-01-26 | 13G | ArriVent BioPharma, Inc. Common Stock AVBP |
LAV Fund VI L.P. | 2,046,123 6.400% |
2,046,123 (New Position) |
Filing History |
| 2024-02-05 4:42 pm Purchase |
2024-01-30 | 13D | ArriVent BioPharma, Inc. Common Stock AVBP |
ORBIMED ADVISORS LLC | 3,027,328 9.100% |
3,027,328 (New Position) |
Filing History |